Format

Send to:

Choose Destination
See comment in PubMed Commons below
BMJ Case Rep. 2010;2010. pii: bcr08.2009.2157. doi: 10.1136/bcr.08.2009.2157. Epub 2010 Feb 19.

Extended remission of metastatic epithelioid angiosarcoma of the heart with liposomal doxorubicin.

Author information

  • 1Santa Maria Hospital, Medicine, Avenida Professor Egas Moniz, Lisbon, 1649-035, Portugal.

Abstract

Angiosarcoma is the most common primary malignant tumour of the heart. It is a rare and aggressive neoplasm that almost always has a short and fatal evolution. By the time it produces symptoms it has usually progressed to a mass causing haemodynamic compromise. Initial presentation with metastatic disease is unusual. We report the case of a 72-year-old man who presented with painful skin lesions on both hands. The skin biopsy was diagnosed as intravascular metastasis of epithelioid angiosarcoma. Body computed tomography scan disclosed a solid mass in the left atrium. The tumour was judged unresectable and the patient was treated with systemic chemotherapy, consisting of liposomal doxorubicin, which resulted in a complete clinical response. The patient remains free of disease after 48 months of follow-up. The excellent clinical evolution of our patient verifies that liposomal doxorubicin may be effective in the treatment of these tumours and significantly prolong patients' lifespan.

PMID:
22347886
[PubMed]
PMCID:
PMC3027499
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk